Publication | Closed Access

Andexanet alfa effectiveness and safety versus four-factor prothrombin complex concentrate (4F-PCC) in intracranial hemorrhage while on apixaban or rivaroxaban: A single-center, retrospective, matched cohort analysis

ThrombosisIntracranial HemorrhageMedicineHematologyHemostasisCohort AnalysisBrain InjuryNeurologyAndexanet Alfa EffectivenessBleeding DisorderCerebral Blood FlowCoagulopathyStrokeAnticoagulantAnesthesiologyHealth Sciences